Overview

Sugammadex/Neostigmine and Liver Transplantation

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Cirrhotic patients undergoing liver transplantation are at very high risk of post operative complication such as post-operative residual curarization. Rocuronium is a neuromuscular blocking agent that nowadays can be safely and rapidly antagonized with sugammadex. No one study compared sugammadex versus neostigmine after rocuronium infusion during liver transplantation.
Phase:
N/A
Details
Lead Sponsor:
Azienda Ospedaliera S. Maria della Misericordia
Treatments:
Neostigmine
Rocuronium